2023-08-012024-07-312024-07-31false08614645STOCKWOOD PHARM LTD2025-04-29falseiso4217:GBPxbrli:pure086146452023-08-01086146452024-07-31086146452023-08-012024-07-31086146452022-08-01086146452023-07-31086146452022-08-012023-07-3108614645bus:SmallEntities2023-08-012024-07-3108614645bus:AuditExempt-NoAccountantsReport2023-08-012024-07-3108614645bus:FullAccounts2023-08-012024-07-3108614645bus:PrivateLimitedCompanyLtd2023-08-012024-07-3108614645core:WithinOneYear2024-07-3108614645core:AfterOneYear2024-07-3108614645core:WithinOneYear2023-07-3108614645core:AfterOneYear2023-07-3108614645core:ShareCapital2024-07-3108614645core:SharePremium2024-07-3108614645core:RevaluationReserve2024-07-3108614645core:OtherReservesSubtotal2024-07-3108614645core:RetainedEarningsAccumulatedLosses2024-07-3108614645core:ShareCapital2023-07-3108614645core:SharePremium2023-07-3108614645core:RevaluationReserve2023-07-3108614645core:OtherReservesSubtotal2023-07-3108614645core:RetainedEarningsAccumulatedLosses2023-07-3108614645core:LandBuildings2024-07-3108614645core:PlantMachinery2024-07-3108614645core:Vehicles2024-07-3108614645core:FurnitureFittings2024-07-3108614645core:OfficeEquipment2024-07-3108614645core:NetGoodwill2024-07-3108614645core:IntangibleAssetsOtherThanGoodwill2024-07-3108614645core:ListedExchangeTraded2024-07-3108614645core:UnlistedNon-exchangeTraded2024-07-3108614645core:LandBuildings2023-07-3108614645core:PlantMachinery2023-07-3108614645core:Vehicles2023-07-3108614645core:FurnitureFittings2023-07-3108614645core:OfficeEquipment2023-07-3108614645core:NetGoodwill2023-07-3108614645core:IntangibleAssetsOtherThanGoodwill2023-07-3108614645core:ListedExchangeTraded2023-07-3108614645core:UnlistedNon-exchangeTraded2023-07-3108614645core:LandBuildings2023-08-012024-07-3108614645core:PlantMachinery2023-08-012024-07-3108614645core:Vehicles2023-08-012024-07-3108614645core:FurnitureFittings2023-08-012024-07-3108614645core:OfficeEquipment2023-08-012024-07-3108614645core:NetGoodwill2023-08-012024-07-3108614645core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108614645core:ListedExchangeTraded2023-08-012024-07-3108614645core:UnlistedNon-exchangeTraded2023-08-012024-07-3108614645core:MoreThanFiveYears2023-08-012024-07-3108614645core:Non-currentFinancialInstruments2024-07-3108614645core:Non-currentFinancialInstruments2023-07-3108614645dpl:CostSales2023-08-012024-07-3108614645dpl:DistributionCosts2023-08-012024-07-3108614645core:LandBuildings2023-08-012024-07-3108614645core:PlantMachinery2023-08-012024-07-3108614645core:Vehicles2023-08-012024-07-3108614645core:FurnitureFittings2023-08-012024-07-3108614645core:OfficeEquipment2023-08-012024-07-3108614645dpl:AdministrativeExpenses2023-08-012024-07-3108614645core:NetGoodwill2023-08-012024-07-3108614645core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108614645dpl:GroupUndertakings2023-08-012024-07-3108614645dpl:ParticipatingInterests2023-08-012024-07-3108614645dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3108614645core:ListedExchangeTraded2023-08-012024-07-3108614645dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3108614645core:UnlistedNon-exchangeTraded2023-08-012024-07-3108614645dpl:CostSales2022-08-012023-07-3108614645dpl:DistributionCosts2022-08-012023-07-3108614645core:LandBuildings2022-08-012023-07-3108614645core:PlantMachinery2022-08-012023-07-3108614645core:Vehicles2022-08-012023-07-3108614645core:FurnitureFittings2022-08-012023-07-3108614645core:OfficeEquipment2022-08-012023-07-3108614645dpl:AdministrativeExpenses2022-08-012023-07-3108614645core:NetGoodwill2022-08-012023-07-3108614645core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3108614645dpl:GroupUndertakings2022-08-012023-07-3108614645dpl:ParticipatingInterests2022-08-012023-07-3108614645dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3108614645core:ListedExchangeTraded2022-08-012023-07-3108614645dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3108614645core:UnlistedNon-exchangeTraded2022-08-012023-07-3108614645core:NetGoodwill2024-07-3108614645core:IntangibleAssetsOtherThanGoodwill2024-07-3108614645core:LandBuildings2024-07-3108614645core:PlantMachinery2024-07-3108614645core:Vehicles2024-07-3108614645core:FurnitureFittings2024-07-3108614645core:OfficeEquipment2024-07-3108614645core:AfterOneYear2024-07-3108614645core:WithinOneYear2024-07-3108614645core:ListedExchangeTraded2024-07-3108614645core:UnlistedNon-exchangeTraded2024-07-3108614645core:ShareCapital2024-07-3108614645core:SharePremium2024-07-3108614645core:RevaluationReserve2024-07-3108614645core:OtherReservesSubtotal2024-07-3108614645core:RetainedEarningsAccumulatedLosses2024-07-3108614645core:NetGoodwill2023-07-3108614645core:IntangibleAssetsOtherThanGoodwill2023-07-3108614645core:LandBuildings2023-07-3108614645core:PlantMachinery2023-07-3108614645core:Vehicles2023-07-3108614645core:FurnitureFittings2023-07-3108614645core:OfficeEquipment2023-07-3108614645core:AfterOneYear2023-07-3108614645core:WithinOneYear2023-07-3108614645core:ListedExchangeTraded2023-07-3108614645core:UnlistedNon-exchangeTraded2023-07-3108614645core:ShareCapital2023-07-3108614645core:SharePremium2023-07-3108614645core:RevaluationReserve2023-07-3108614645core:OtherReservesSubtotal2023-07-3108614645core:RetainedEarningsAccumulatedLosses2023-07-3108614645core:NetGoodwill2022-08-0108614645core:IntangibleAssetsOtherThanGoodwill2022-08-0108614645core:LandBuildings2022-08-0108614645core:PlantMachinery2022-08-0108614645core:Vehicles2022-08-0108614645core:FurnitureFittings2022-08-0108614645core:OfficeEquipment2022-08-0108614645core:AfterOneYear2022-08-0108614645core:WithinOneYear2022-08-0108614645core:ListedExchangeTraded2022-08-0108614645core:UnlistedNon-exchangeTraded2022-08-0108614645core:ShareCapital2022-08-0108614645core:SharePremium2022-08-0108614645core:RevaluationReserve2022-08-0108614645core:OtherReservesSubtotal2022-08-0108614645core:RetainedEarningsAccumulatedLosses2022-08-0108614645core:AfterOneYear2023-08-012024-07-3108614645core:WithinOneYear2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:CostValuation2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3108614645core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3108614645core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3108614645core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3108614645core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3108614645core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3108614645core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3108614645core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3108614645core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3108614645core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3108614645core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3108614645core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3108614645bus:Director12023-08-012024-07-3108614645core:FurnitureFittingsToolsEquipment2023-07-3108614645core:FurnitureFittingsToolsEquipment2023-08-012024-07-3108614645core:FurnitureFittingsToolsEquipment2024-07-31

STOCKWOOD PHARM LTD

Registered Number
08614645
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2024

STOCKWOOD PHARM LTD
Company Information
for the year from 1 August 2023 to 31 July 2024

Director

Mr M Tanveer

Registered Address

74-76 Hollway Road
Bristol
BS14 8PG

Registered Number

08614645 (England and Wales)
STOCKWOOD PHARM LTD
Balance Sheet as at
31 July 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3350,672453,871
Tangible assets4215,5099,842
566,181463,713
Current assets
Stocks549,12547,425
Debtors61,160,415731,408
Cash at bank and on hand83,302289,974
1,292,8421,068,807
Creditors amounts falling due within one year7(843,123)(645,571)
Net current assets (liabilities)449,719423,236
Total assets less current liabilities1,015,900886,949
Creditors amounts falling due after one year8(500,000)(500,000)
Net assets515,900386,949
Capital and reserves
Called up share capital100100
Profit and loss account515,800386,849
Shareholders' funds515,900386,949
The financial statements were approved and authorised for issue by the Director on 29 April 2025, and are signed on its behalf by:
Mr M Tanveer
Director
Registered Company No. 08614645
STOCKWOOD PHARM LTD
Notes to the Financial Statements
for the year ended 31 July 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Intangible assets
Goodwill, being the amount paid in connection with the acquisition of a business in 2013 and 2021, is being amortised evenly over its estimated useful life of 10 years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings-10
Plant and machinery25-
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year2424
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 August 231,051,9951,051,995
At 31 July 241,051,9951,051,995
Amortisation and impairment
At 01 August 23598,124598,124
Charge for year103,199103,199
At 31 July 24701,323701,323
Net book value
At 31 July 24350,672350,672
At 31 July 23453,871453,871
4.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Total

££££
Cost or valuation
At 01 August 2330,09721,875-51,972
Additions-119,669121,434241,103
At 31 July 2430,097141,544121,434293,075
Depreciation and impairment
At 01 August 2327,61014,520-42,130
Charge for year2,48726,7706,17935,436
At 31 July 2430,09741,2906,17977,566
Net book value
At 31 July 24-100,254115,255215,509
At 31 July 232,4877,355-9,842
5.Stocks

2024

2023

££
Finished goods49,12547,425
Total49,12547,425
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables446,054239,936
Other debtors714,361491,472
Total1,160,415731,408
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables284,405300,632
Bank borrowings and overdrafts285,437-
Taxation and social security6,91839,886
Payments received on account193,749202,145
Other creditors68,11478,407
Accrued liabilities and deferred income4,50024,501
Total843,123645,571
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Creditors: amounts due after one year

2024

2023

££
Other creditors500,000500,000
Total500,000500,000